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An equation from the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) provides more accurate estimates
of the glomerular filtration rate (eGFR) than that from the
modification of diet in renal disease (MDRD) Study, although
both include a two-level variable for race (Black and White
and other). Since creatinine generation differs among ethnic
groups, it is possible that a multilevel ethnic variable would
allow more accurate estimates across all groups. To evaluate
this, we developed an equation to calculate eGFR that
includes a four-level race variable (Black, Asian, Native
American and Hispanic, and White and other) using a
database of 8254 patients pooled from 10 studies. This
equation was then validated in 4014 patients using 17
additional studies from the United States and Europe
(validation database), and in 1022 patients from China (675),
Japan (248), and South Africa (99). Coefficients for the Black,
Asian, and Native American and Hispanic groups resulted in
15, 5, and 1% higher levels of eGFR, respectively, compared
with the White and other group. In the validation database,
the two-level race equation had minimal bias in Black, Native
American and Hispanic, and White and other cohorts. The
four-level ethnicity equation significantly improved bias in
Asians of the validation data set and in Chinese. Both
equations had a large bias in Japanese and South African
patients. Thus, heterogeneity in performance among the
ethnic and geographic groups precludes use of the four-
level race equation. The CKD-EPI two-level race equation can
be used in the United States and Europe across a wide range
of ethnicity.
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Chronic kidney disease (CKD) is a worldwide health
problem, affecting all racial and ethnic groups that have
been investigated.1 In the United States, chronic kidney
failure disproportionately burdens racial and ethnic minor-
ities. Incidence rates for chronic kidney failure treated by
dialysis and transplantation are 3.6 and 1.4 times higher in
Blacks and Asians, respectively, compared with Whites, and
1.5 times higher in Hispanics compared with non-Hispanics.2
Outside of the United States, Taiwan and Japan have the
highest prevalence rates of treated kidney failure.2,3 Data on
the prevalence, etiology, and outcomes of earlier stages of
kidney disease in these groups are likely to be inaccurate due,
at least in part, to the lack of accurate glomerular filtration
rate (GFR) estimates.
The Modification of Diet in Renal Disease (MDRD) Study
equation utilizes a two-level variable for race (Black vs White
and other). The coefficient for Blacks leads to higher values
for estimated GFR (eGFR) compared with Whites for the
same level of creatinine, because of differences between
Blacks vs Whites in factors other than GFR that affect the
serum level of creatinine (non-GFR determinants), especially
higher creatinine generation from muscle and diet.4,5 It is
widely believed that there are also differences in creatinine
generation in other racial, ethnic, and geographic groups,
which are not captured by current equations.6,7 Consistent
with this assumption, introduction of coefficients for use in
the MDRD Study equation in China and Japan improves its
performance in these populations.8,9
We recently reported a new equation, the Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI) equation,
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based on creatinine, age, sex, and a two-level variable for race,
which is more accurate than the MDRD Study equation,
particularly at higher levels of GFR and in populations
without CKD,5,10,11 and provides better risk prediction.12,13
We hypothesized that the performance of the CKD-EPI
equation could be further improved in Asians and in Native
Americans and Hispanics by utilizing coefficients specific
for these groups. In this study, we report on the development
of an GFR-estimating equation that includes a four-level race
variable in a diverse population from the United States and
Europe, and its evaluation compared with the CKD-EPI
(two-level race) equation in separate populations from the
United States and Europe as well as in populations from
other countries.
RESULTS
The clinical characteristics differed significantly among racial
and ethnic groups. In the development data set (Table 1a),
mean measured GFR ranged from 55 to 73ml/min per 1.73m2
among racial/ethnic groups, and was lower in Blacks and Asians
and higher in Native Americans and Hispanics compared with
Whites and others. Blacks were older, more likely to be female,
and had a larger body size compared with the other groups. In
the CKD-EPI external validation data set, measured GFR
ranged from 53 to 105ml/min per 1.73m2 and was lower in
Asians and higher in Native Americans and Hispanics
compared with Whites and others (Table 1b). In the non-US
and Europe validation data set, measured GFR ranged from 53
and 60ml/min per 1.73m2, and body mass index (BMI) was
lower than in the CKD-EPI development and validation data
sets (Table 1b). Supplementary Appendix A and B describe the
distribution of race and ethnic groups for each study.
Table 2 shows the coefficients for each race and ethnic
groups refit in the CKD-EPI combined development and
internal validation data set. The coefficients for Black and
Asian are significantly larger than the reference group (White
and other), resulting in higher eGFR for the same level of
creatinine. The coefficient for Native American and Hispanic
was smaller and not statistically significant, but was retained
in the model. For both the two- and four-level race
equations, eGFR is 15% higher for Blacks than for Whites
or others. In the four-level race equation, eGFR is 5% higher
in Asians but only 1% higher in Native Americans and
Hispanics compared with Whites or others. Table 3 shows the
two- and four-level race equations developed using the
coefficients from the combined development and internal
validation data sets, expressed for different combinations of
race, sex, and serum creatinine.
Tables 4 and 5 show the performance of both models
in the two external validation data sets. In the CKD-EPI
Table 1a | Clinical characteristics of the participants in development data sets
Race/ethnicity
Variable Overall White and other Black Asian
Native American
and Hispanic P-values
N 8254 5216 2585 100 353
Age, mean (s.d.) in years 47 (15) 44 (15) 53 (12) 49 (15) 43 (12) o0.001
Age categories, N (%) o0.001
o40 years 3076 (37) 2464 (47) 422 (16) 36 (36) 154 (44)
40–65 years 4154 (50) 2149 (41) 1766 (68) 50 (50) 189 (54)
465 years 1024 (12) 603 (11) 397 (16) 14 (11) 10 (3)
Sex, N (%) o0.001
Female 3606 (44) 2353 (45) 1019 (39) 41 (41) 193 (55)
Male 4648 (56) 2863 (55) 1566 (61) 59 (59) 160 (45)
Diabetes, N (%) o0.001
Yes 2406 (29) 1885 (36) 280 (11) 33 (33) 208 (59)
No 5848 (71) 3331 (64) 2305 (89) 67 (67) 145 (41)
Transplant, N (%) o0.001
Yes 360 (4) 330 (6) 24 (1) 5 (5) 1 (0.3)
No 7894 (96) 4886 (94) 2561 (99) 95 (95) 352 (100)
GFR mean (s.d.), ml/min per 1.73 m2 68 (40) 73 (43) 55 (27) 57 (31) 90 (45) o0.001
Serum creatinine, mean (s.d.), mg/dl 1.66 (1.16) 1.58 (1.19) 1.87 (1.09) 1.73 (0.91) 1.23 (1.02) o0.001
Body surface area, mean (s.d.), m2 1.91 (0.24) 1.90 (0.23) 2.00 (0.25) 1.77 (0.21) 1.91 (0.25) o0.001
BMI, mean (s.d.), kg/m2 28 (6) 27 (5) 31 (7) 26 (5) 31 (9) o0.001
BMI categories, N (%) o0.001
o20 kg/m2 287 (3) 218 (4) 60 (2) 4 (4) 5 (1)
20–25 kg/m2 2447 (30) 1896 (36) 446 (17) 40 (40) 65 (18)
26–30 kg/m2 2922 (35) 1930 (37) 857 (33) 37 (37) 98 (28)
430 kg/m2 2598 (31) 1172 (23) 1222 (47) 19 (19) 185 (52)
Abbreviations: BMI, body mass index; GFR, glomerular filtration rate.
To convert GFR from ml/min per 1.73m2 to ml/s per 1.73m2, multiply by 0.0167.
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validation data set, performance of the equation with the
two- and four-level race terms was similar in both the Black
and White and other groups (Table 4). In Asians, there was a
significant improvement in bias and root mean square error
with the four-level compared with the two-level equation
(0.8 (2.2, 2.6) ml/min per 1.73m2 vs 2.1 (0.3, 4.4) ml/min
per 1.73m2 (Po0.005) and 0.293 (0.178, 0.424) vs 0.302
(0.188, 0.436), P¼ 0.003)), but there was a small higher
interquartile range with the four-level equations (12.3
(9.0, 16.1) vs 10.5 (8.0, 14.6) ml/min per 1.73m2
(P¼ 0.001)) and no significant difference in percentage of
estimates within 30% of the measured GFR (P30). There were
no significant differences in performance between the two
equations for Native Americans and Hispanics. In the
Chinese data set (Table 5, column 1), as in the Asians in
the CKD-EPI validation data set, there was an improvement
in performance with the four-level race equation compared
with the two-level race equation in bias (1.3 (0.6, 2.2) vs 2.7
(1.9, 3.7) ml/min per 1.73m2 (Po0.0001)), interquartile
range (15.5 (14.4, 17.4) vs 16.7 (15.0, 18.5) ml/min per 1.73m2,
Po0.0001), root mean square error (0.318 (0.295, 0.343) vs
0.325 (0.302, 0.348) ml/min per 1.73m2, P¼ 0.002)), as well as
in P30 (72.1 (68.7, 75.7) vs 73.2 (69.9, 76.6), P¼ 0.01). In the
Japanese data set (Table 5, column 2), performance for the two-
level race equation was substantially worse than for the Asians in
the CKD-EPI validation data set and not improved with the use
of the four-level race equation. In the South African data set
(Table 5, column 3), performance of both the two- and four-
level race equations was substantially worse than for the Blacks
in the CKD-EPI validation data set. Performance was better for
the South African data set when the Black coefficient was not
used (bias of 12.4 (18.3, 7.6) with the use of the Black
term vs 4.9 (7.0, 0.5) ml/min per 1.73m2 without the use
of the Black term).
Figure 1 summarizes the comparison of bias between the
two- and four-level race equation by level of eGFR within
Table 1b | Clinical characteristics of the participants in validation data sets
CKD-EPI (US and Europe) Non-US and Europe
Variable White and other Black Asian
Native American
and Hispanic Asian Asian Black P-values
N 3378 384 67 185 248 675 99
Age, mean (s.d.) in years 49 (15) 50 (15) 51 (15) 45 (12) 50 (18) 50 (15) 47 (17) 0.001
Age categories, N (%) o0.001
o40 years 978 (29) 112 (29) 19 (28) 68 (37) 95 (38) 207 (31) 42 (43)
40–65 years 1898 (56) 224 (58) 35 (52) 107 (58) 92 (37) 333 (49) 42 (43)
465 years 502 (15) 48 (13) 13 (19) 10 (5) 61 (25) 135 (20) 15 (15)
Sex, N (%) 0.001
Female 1513 (45) 184 (48) 32 (48) 130 (70) 112 (45) 328 (49) 49 (49)
Male 1865 (55) 200 (52) 35 (52) 55 (30) 136 (55) 347 (51) 50 (50)
Diabetes, N (%) o0.001
Yes 975 (29) 95 (25) 14 (21) 119 (64) 35(14) 21(3) 6 (6)
No 2403 (71) 289 (75) 53 (79) 66 (67) 213 (86) 654 (97) 93 (94)
Transplant, N (%) o0.001
Yes 1072 (32) 52 (14) 7 (10) 3 (2) 0 0 0
No 2306 (68) 332 (86) 60 (90) 182 (98) 0 0 0
GFR, mean (s.d.), ml/min per 1.73m2 69 (36) 62 (34) 53 (31) 105 (47) 53 (31) 55 (35) 61 (32) o0.001
Serum creatinine, mean (s.d.), mg/dl 1.48 (0.94) 1.80 (0.29) 1.99 (1.41) 0.90 (0.73) 1.24 (0.56) 2.25 (2.18) 1.77 (1.71) o0.001
Body surface area, mean (s.d.), m2 1.90 (0.23) 1.95 (0.23) 1.70 (0.20) 1.98 (0.29) 1.62 (0.18) 1.71 (0.18) 1.77 (0.17) o0.001
BMI, mean (s.d.), kg/m2 27 (5) 30 (7) 24 (4) 34 (8) 23 (4) 24 (4) 26 (5) o0.001
BMI categories, N (%) o0.001
o20 kg/m2 225 (7) 17 (4) 5 (7) 2 (1) 55 (22) 107 (16) 15 (15)
20–25 kg/m2 1223 (36) 84 (22) 34 (51) 22 (12) 137 (55) 354 (52) 44 (44)
25–30 kg/m2 1178 (35) 115 (30) 24 (36) 49 (26) 45(18) 181 (27) 20 (20)
430 kg/m2 752 (22) 168 (44) 4 (6) 112 (61) 11 (4 ) 33 (5) 20 (20)
Abbreviations: BMI, body mass index; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate.
To convert GFR from ml/min per 1.73m2 to ml/s per m2, multiply by 0.0167.
Table 2 | Race/ethnicity coefficients (95% confidence intervals)a
Equation White and other Black Asian Native American and Hispanic
Two-level race 1.0 (reference group) 1.157 (1.144, 1.170) 1.0 1.0
Four-level race 1.0 (reference group) 1.160 (1.146, 1.173) 1.052 (1.004, 1.102) 1.010 (0.984, 1.037)
Coefficients are adjusted for creatinine, sex, and age.
aCorresponds to percent increase in estimated glomerular filtration rate (eGFR) for the same level of serum creatinine.
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each racial/ethnic category. In the CKD-EPI validation data
set, using either the two- and four-level race equation, bias
was less than B5ml/min per 1.73m2 except for Blacks with
eGFR 490ml/min per 1.73m2, as we have previously
reported. In the Asians in the CKD-EPI data set and in the
Chinese data sets, the bias exceeded 5ml/min per 1.73m2
for some eGFR groups, but improved with the use of the
four-level race equation. For both equations, the bias varied
substantially throughout the eGFR range in the Japanese and
South African data sets.
DISCUSSION
Differences across race and ethnic groups in relationships
between serum creatinine and measured GFR primarily
Table 3 | CKD-EPI equation for estimating GFR on the natural scale expressed for race, sex, and range of serum creatinine
Race Sex Serum creatinine eGFR (ml/min per 1.73m2)
Two-level race equation
Black Female p0.7mg/dl 166 (0.993)Age (Scr/0.7)0.329
Black Female 40.7mg/dl 166 (0.993)Age (Scr/0.7)1.209
Black Male p0.9mg/dl 163 (0.993)Age (Scr/0.9)0.411
Black Male 40.9mg/dl 163 (0.993)Age (Scr/0.9)1.209
White and other Female p0.7mg/dl 144 (0.993)Age (Scr/0.7)0.329
White and other Female 40.7mg/dl 144 (0.993)Age (Scr/0.7)1.209
White and other Male p0.9mg/dl 141 (0.993)Age (Scr/0.9)0.411
White and other Male 40.9mg/dl 141 (0.993)Age (Scr/0.9)1.209
Four-level race equation
Black Female p0.7 167 (0.993)Age (Scr/0.7)0.328
Black Female 40.7 167 (0.993)Age (Scr/0.7)1.210
Black Male p0.9 164 (0.993)Age (Scr/0.9)0.412
Black Male 40.9 164 (0.993)Age (Scr/0.9)1.210
Asian Female p0.7 151 (0.993)Age (Scr/0.7)0.328
Asian Female 40.7 151 (0.993)Age (Scr/0.7)1.210
Asian Male p0.9 149 (0.993)Age (Scr/0.9)0.412
Asian Male 40.9 149 (0.993)Age (Scr/0.9)1.210
Hispanic and Native American Female p0.7 145 (0.993)Age (Scr/0.7)0.328
Hispanic and Native American Female 40.7 145 (0.993)Age (Scr/0.7)1.210
Hispanic and Native American Male p0.9 143 (0.993)Age (Scr/0.9)0.412
Hispanic and Native American Male 40.9 143 (0.993)Age (Scr/0.9)1.210
White and other Female p0.7 144 (0.993)Age (Scr/0.7)0.328
White and other Female 40.7 144 (0.993)Age (Scr/0.7)1.210
White and other Male p0.9 141 (0.993)Age (Scr/0.9)0.412
White and other Male 40.9 141 (0.993)Age (Scr/0.9)1.210
Abbreviations: CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate.
To convert GFR from ml/min per 1.73m2 to ml/s per 1.73m2, multiply by 0.0167. To convert serum creatinine from mg/dl to mmol/l, multiply by 88.4. CKD-EPI equation
coefficients derived from pooled development and internal validation data sets.
CKD-EPI two-level race equation expressed as a single equation: GFR=141min(Scr/k, 1)amax(Scr/k, 1)1.209 0.993Age 1.018 [if female] 1.159 [if black] where Scr is
serum creatinine, k is 0.7 for females and 0.9 for males, a is 0.329 for females and 0.411 for males, min indicates the minimum of Scr/k or 1, and max indicates the
maximum of Scr/k or 1.
The four-level equation expressed as a single equation: GFR=141min(Scr/k, 1)amax(Scr/k, 1)1.210 0.993Age 0.993 [if female] 1.16 [if Black] 1.05 [if Asian] 1.01 [if
Hispanic and Native American] where Scr is serum creatinine, k is 0.7 for females and 0.9 for males, a is 0.328 for females and 0.412 for males, min indicates the minimum
of Scr/k or 1, and max indicates the maximum of Scr/k.
In the table, the multiplication factors for race and sex are incorporated into the intercept, resulting in different intercepts for age and sex combinations.
Table 4 | Performance in CKD-EPI external validation data set (US and Europe) by race/ethnicity
Measures Equation Total White and other Black Asian
Native American
and Hispanic
N 4014 3378 384 67 185
Bias, ml/min per 1.73m2 Two-level 2.5 (2.1, 2.9) 2.8 (2.4, 3.2) 0.8 (2.0, 0.6) 2.1 (0.3, 4.4) 2.3 (2.1, 5.1)
Four-level 2.5 (2.1, 2.9) 2.9 (2.5, 3.4) 0.9 (2.0, 0.6) 0.8 (2.2, 2.6) 1.6 (3.0, 4.2)
IQR, ml/min per 1.73m2 Two-level 17.0 (16.1, 17.6) 16.8 (16.0, 17.6) 15.1 (12.6, 17.6) 10.5 (8.0, 14.6) 25.6 (20.8, 32.0)
Four-level 17.0 (16.2, 17.6) 16.8 (16.0, 17.6) 15.1 (12.6, 17.6) 12.3 (9.0, 16.1) 26.1 (20.8, 32.2)
P30, % Two-level 84 (83, 85) 84 (83, 86) 82 (78, 85) 85 (76, 93) 80 (74, 85)
Four-level 84 (83, 85) 84 (83, 85) 82 (80, 85) 85 (76, 93) 81 (76, 87)
RMSE Two-level 0.250 (0.242, 0.259) 0.250 (0.240, 0.258) 0.242 (0.221, 0.265) 0.302 (0.188, 0.436) 0.265 (0.223, 0.310)
Four-level 0.250 (0.242, 0.259) 0.250 (0.240, 0.259) 0.243 (0.221, 0.266) 0.293 (0.178, 0.424) 0.264 (0.222, 0.310)
Abbreviations: CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; IQR, interquartile range, 25–75th percentile; P30, percentage of
GFR estimates within 30% of measured GFR; RMSE, root mean square error.
Bias is calculated as measured GFRestimated GFR.
Numbers in brackets are 95% confidence intervals.
To convert GFR from ml/min per 1.73m2 to ml/s per 1.73m2, multiply by 0.0167.
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reflect variation in creatinine generation because of muscle
mass or diet. The definition of the race coefficient as Black vs
White and other in the MDRD Study does not account for
differences in creatinine generation among other racial and
ethnic groups. In the process of developing the CKD-EPI
equation, we sought to develop an equation that better
captures the variation in creatinine generation among racial
and ethnic groups other than Blacks and Whites. The results
of this process are described in this study. The four-level
race equation that was developed is more accurate than the
CKD-EPI (two-level race) equation in some, but not all,
populations, and both equations demonstrated heteroge-
neous results within racial and ethnic groups across
geographic regions. Given these results, we concluded that
the four-level race equation was not sufficiently accurate to be
implemented in clinical practice, and had selected the CKD-
EPI equation with its two-level race variable.10 Nevertheless,
these results are informative for use of the two-level race
CKD-EPI equation in these groups, and also suggest future
research directions to derive generalizable racial and ethnic
coefficients for GFR-estimating equations based on serum
creatinine.
The coefficient for Blacks in the two- and four-level race
term yielded a 15% higher eGFR for Blacks than for Whites at
a given serum creatinine level, which is consistent with
physiological data showing greater skeletal muscle mass in
Blacks than otherwise equivalently matched White sub-
jects.14,15 Similarly, African Black athletes also have greater
lean body mass compared with Whites.16 Using either
equation, the eGFR for Blacks in the CKD-EPI validation
data set accurately estimated measured GFR. In contrast,
these equations led to an overestimation of measured GFR by
12ml/min per 1.73m2 in the South African data. This
indicates a different relationship between serum creatinine
and GFR for Black South Africans vs US and European
Blacks, as shown previously for the MDRD Study equation
Table 5 | Performance in non-US and Europe external validation data set by country and race/ethnicity
Measures Equation China (Asian) Japan (Asian) South Africa (Black)
N 675 248 99
Bias, ml/min per 1.73m2 Two-level 2.7 (1.9, 3.7) 17.8 (20.1, 14.7) 12.4 (18.3, 7.6)
Four-level 1.3 (0.6, 2.2) 21.4 (23.3, 18.2) 12.5 (18.3, 7.6)
IQR, ml/min per 1.73m2 Two-level 16.7 (15.0, 18.5) 21.0 (18.5, 23.9) 28.0 (20.8, 33.3)
Four-level 15.5 (14.4, 17.4) 23.5 (20.4, 26.0) 28.0 (20.8, 33.4)
P30, % Two-level 73.2 (69.9, 76.6) 29.4 (23.8, 35.1) 55.6 (46.5, 64.6)
Four-level 72.1 (68.7, 75.7) 36.3 (30.6, 42.3) 55.6 (46.5, 64.6)
RMSE Two-level 0.325 (0.302, 0.348) 0.469 (0.424, 0.515) 0.326 (0.292, 0.361)
Four-level 0.318 (0.295, 0.343) 0.507 (0.463, 0.553) 0.327 (0.292, 0.362)
Abbreviations: CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; IQR, interquartile range, 25–75th percentile; P30, percentage of
GFR estimates within 30% of measured GFR; RMSE, root mean square error.
Bias is calculated as measured GFRestimated GFR.
Numbers in brackets are 95% confidence intervals.
To convert GFR from ml/min per 1.73m2 to ml/s per 1.73m2, multiply by 0.0167.
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Figure 1 |Performance by level of estimated glomerular filtration rate (eGFR): Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) validation data set.
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using these data17 as well as in a separate population in
Ghana.18 This difference may be because of lower muscle
mass in African Blacks compared with African Americans,
potentially secondary to poorer diet or overall health, related
to HIV infection or other chronic diseases. Indeed, the mean
BMI in the Ghanaian and South African populations was
lower than in the Blacks in the CKD-EPI validation data set. In
a previous publication, we showed that the CKD-EPI equation
overestimates measured GFR in people with low BMI.5 Our
data from South Africa, as well as the data from Ghana,
demonstrated that GFR estimates are more accurate if the
Black term is omitted. These data raise important questions
about the appropriateness of use of the Black coefficient in the
CKD-EPI and MDRD Study equations for GFR estimation in
Blacks outside the United States and Europe.
The Asian coefficient in the four-level race equation
translates into a 5% higher GFR at a given serum creatinine
value compared with Whites and others. This is unexpected,
given that some previous physiological and epidemiological
data suggest that Asians have less muscle mass and lower
dietary intake than Whites. For example, in an analysis of
people in Pakistan, participants had lower mean creatinine
excretion rates than those estimated for age- and gender-
matched white individuals.19 In other studies, Asians have
been shown to have a higher percent body fat for the same level
of BMI than Whites, suggesting lower levels of muscle mass.20
The direction of the Asian coefficient is consistent with the
modification of the MDRD Study equation for Chinese
reported by Ma et al.,8 whose data are included here as part
of the non-US and Europe validation data set. Although the 5%
higher eGFR was substantially lower than the 23% reported by
Ma et al.,8 they are both in contrast to the Japanese coefficient
for the modification of the MDRD Study and CKD-EPI
equations of 0.808 (ref. 9) and 0.8132 (ref. 21), respectively,
which translate to a 19% lower GFR at a given serum creatinine.
The Asian coefficient in the four-level race equation led to
more accurate GFR estimates in Asians in the CKD-EPI
validation data set as well as in the Chinese data set, but neither
the two-level or four-level equation resulted in accurate
estimates in the Japanese. Both the Chinese and Japanese
cohorts had a greater proportion of people with BMI o20 kg/
m2 than the CKD-EPI development and validation data sets,
but were similar to each other, suggesting that the over-
estimation of measured GFR in the Japanese cohort is not
related solely to differences in levels of BMI. Factors other than
muscle mass and diet may explain the difference between the
Chinese and Japanese coefficients, such as differences in GFR
measurement methods and the accuracy of creatinine calibra-
tion.22 The countries of origin for the Asians in the CKD-EPI
data sets are not known, and therefore we are not able to
ascertain whether the Asian coefficient 41.0 in the four-level
race CKD-EPI equation reflects Chinese origin. If future
analyses establish that creatinine generation varies among
Asian groups, then coefficients for subgroups of Asians in the
CKD-EPI and other creatinine-based equations will need to
reflect this variation.
The Native American and Hispanic coefficient resulted in
a nonstatistically significant 1% higher eGFR for each serum
creatinine value compared with Whites and others, and did
not improve GFR estimation, suggesting that modification of
the CKD-EPI equation may not be necessary for GFR
estimation in Native Americans and Hispanics. To our
knowledge, this is the only demonstration of the performance
of the CKD-EPI equation in these groups. We are not aware
of data on muscle mass in Native American and Hispanic
populations. Data from NHANES (National Health and
Nutrition Examination Survey) show a 5.3% lower mean
level of serum creatinine for young healthy Mexican
American men compared with Whites,4 which has been
interpreted as lower creatinine generation, but it may also
reflect higher GFR. Furthermore, there is likely to be
heterogeneity among Hispanic populations based on country
of origin. There are only a small number of Native Americans
and Hispanics in the CKD-EPI development data set and we
do not have information on their country of origin.
The strengths of this study include the large diverse study
population, with and without kidney diseases; calibration of
the creatinine assays in each study to standardized values;
rigorous and sophisticated statistical techniques for equation
development; and evaluation of the equations in a separate
data set of multiple studies that maximized external
generalizability.
Our database had several limitations. First, it included
only a small number of non-Blacks and non-Whites in both
the CKD-EPI development and validation data sets. None-
theless, the confidence intervals for the Asian and Native
American and Hispanic coefficients were narrow, suggesting
little variability among these groups in non-GFR determi-
nants of serum creatinine. Second, the studies used a variety
of methods to measure GFR that may have affected model
evaluation. Finally, because we did not have information on
country of origin for Asians and Hispanics in the CKD-EPI
data sets, we grouped all Asians together and also grouped
Hispanics and Native Americans, limiting a more nuanced
analysis. Finally, the studies differed in their racial distribu-
tions, and hence the race effects cannot be entirely
disentangled from study differences. Nevertheless, compar-
ison of equations in a separate validation data set overcomes
some of the limitations of differences among studies in
patient characteristics and methods for measurement of GFR
and serum creatinine, and provides support for the general-
ization of these results.
This study has several implications for clinical practice
and research. First, the MDRD Study equation is currently
widely used by clinicians, researchers, and public health
officials, and is automatically reported by clinical laboratories
whenever serum creatinine is ordered in the United States
and Canada as well as in several countries in Europe.23 In
these countries, we suggest that the CKD-EPI (two-level race)
equation could be used across a wide range of race and
ethnicity, with the understanding that there is likely to be
variation in accuracy of GFR estimates among and within
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racial and ethnic groups based on factors associated with
variation in creatinine generation, just as there is variation in
accuracy within age and sex groups. Additional studies with a
greater number and better characterization of participants
from racial and ethnic minorities are necessary to develop
more accurate estimates. Second, in geographic regions outside
the United States and Europe, differences in creatinine
generation within race and ethnic groups may limit the
application of any creatinine-based estimating equation, unless
the equation was specifically developed in that region. This
limitation could possibly apply to immigrants of the same race
and ethnicity from one region to another. Before recommend-
ing the CKD-EPI equation (or any creatinine-based estimating
equation) in clinical practice, studies are required to determine
whether modifications to the CKD-EPI (two-level race)
equation are necessary.8,21 Third, emphasis should be placed
on investigation of filtration markers that may be less affected
than creatinine by race and ethnicity, such as cystatin C and
other novel markers.
In summary, racial differences in performance of creati-
nine-based estimating equation likely reflect geographic and
ethnic differences rather than race per se. The four-level race
equation was more accurate in some populations but not all.
The CKD-EPI (two-level race) equation can be used in the
United States and Europe across a wide range of race and
ethnicity with appropriate attention to factors that affect
creatinine generation.
MATERIALS AND METHODS
Sources of data and measurements
CKD-EPI is a research group funded by the NIDDK (National
Institute of Diabetes, Digestive and Kidney Disease) to address
challenges in the study and care of CKD, including development and
validation of improved GFR-estimating equations by pooling data
from research studies and clinical populations (hereafter referred to
as ‘studies’).10 The design and studies have been previously
described and are briefly reviewed here.10 We developed and
internally validated the CKD-EPI equation in a database of 10
studies with a total of 8254 participants, divided randomly into
separate data sets for development (n¼ 5504) and internal
validation (n¼ 2750). The equations were then externally validated
in a separate data set of 16 other studies with a total of 3896
participants. In the current report, we use the same data set as
previously described for development and internal validation.10 We
also use the same external validation data set as previously
described,10 with the addition of data from Native Americans that
were not available in the original report because of absence of
creatinine calibration at the time of the original report, but now
available to us (herein referred to as ‘CKD-EPI validation data set’)
(N¼ 4014). We also evaluated the equations in three separate
studies from outside of United States and Europe; two are from
Asia8,21 (referred to as ‘China’ and ‘Japan’) and one is from South
Africa17 (referred to as ‘South Africa’), each of which has been
previously described (herein referred together as ‘non-US and
Europe validation data sets’).
GFR was measured using urinary clearance of iothalamate in the
development data set and iothalamate and other filtration markers
in the external validation data sets (Supplementary Appendix A and
Appendix B). Serum creatinine values were calibrated to standar-
dized creatinine measurements using the Roche enzymatic method
(Roche-Hitachi P-Module instrument with Roche Creatininase Plus
assay; Hoffmann–La Roche, Basel, Switzerland) at the Cleveland
Clinic Research Laboratory (Cleveland, OH).24,25
Development and validation
Methods for development and validation have been previously
described in detail.10 In brief, we used least squares linear regression
to relate measured GFR to serum creatinine and clinical character-
istics available in the development data set. Predictor variables
included serum creatinine, age, sex, and race in all equations. GFR
was adjusted for body surface area.26 GFR and serum creatinine were
transformed to natural logarithms to reflect their inverse relation-
ship and satisfy the assumption of a normal error distribution to
stabilize variance across the range of GFR. We tested multiple forms
of creatinine and age, and the final model includes a piecewise linear
spline of log serum creatinine with a knot at 0.7mg/dl in men and
0.9mg/dl in women, and linear age.
Information on race and ethnicity was provided in the original
study data. Race was defined as a two-level variable (Black vs White
and other) and as a four-level variable (Black, Asian, Native
American and Hispanic vs White and other). The specific origin of
Asians was not specified in the original studies. The rationale for
grouping Native Americans and Hispanics together is that the
majority of non-Black Hispanics in the United States are from
Mexico, and they are considered to be of mixed European-Native
American descent.27,28 The rationale for grouping others with White
is that many of the other groups are defined as of Caucasian descent
(for example, Arabs, non-Black, and non-Native American Hispa-
nics). In some studies, information on ethnicity is not available, and
it is possible that some Blacks or Whites were also Hispanics. We
developed models in parallel using two- and four-level variables for
race. Race groups were defined using a categorical variable with all
levels necessarily included in the models using indicator variables.
We selected models to bring forth from development into internal
and then external validation based on analyses of the two-level race
variable, with models using the four-level race variable brought
along in parallel. For clarity of presentation, we will refer to the two
equations as two- and four-level race equations.
Models created in the development database were first validated
in the internal validation database. The development and internal
validation data sets were then combined and equations were refit to
yield more precise final coefficients to be used in subsequent
analyses. Models were then evaluated in the CKD-EPI validation
data set and a final two-level race model was selected using a
prespecified series of steps, as has been previously described.10 The
four-level race variable model presented here is the parallel model to
the final two-level race model, which is known as the CKD-EPI
equation.10 Results are also presented in the non-US and Europe
validation data set by study.
Model performance
Performance of the equations was evaluated using similar metrics in
both the development and two validation databases. Bias was
expressed as the difference (mGFR–eGFR) and percent difference
(100 * [mGFReGFR]/mGFR) between measured GFR (mGFR) and
eGFR, with positive values indicating lower eGFR than mGFR
(underestimation). Precision was expressed as interquartile range for
the differences. Accuracy was expressed as P30 that takes into
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account higher errors at higher values. We defined the probability of
a large error as 1–P30.
Performance was evaluated within subgroups defined by the
following clinical characteristics: age (o40, 40–65, and 465 years),
sex, race (Black, Asian, Native American and Hispanic, and White
and other), diabetes (yes, no), previous organ transplant (yes, no),
and BMI (o20, 20–25, 26–30, and 430 kg/m2). Level of eGFR was
categorized as o60, 60–90, and 490ml/min per 1.73m2.
Confidence intervals were calculated by bootstrap methods (2000
bootstraps) for difference, percent difference, and for P30. Signifi-
cance testing between metrics for each equation was computed using
the Wilcoxon rank test on the bootstrapped estimates. Analyses
were computed using R (Version 2, Free Software Foundation,
Boston, MA) and SAS software (version, 9.1, Cary, NC). Smooth
estimates of the mean in the figures were created using the lowess
function in R.
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